Skip to main content

Table 1 Hematologic parameters of the patient

From: Severe megaloblastic anemia in a patient with advanced lung adenocarcinoma during treatment with erlotinib: a case report and literature review

Weeks after the initiation of Erlotinib

White Blood Count, 109

Cells/L

Hemoglobin level, g/L

Mean Corpuscular Volume, fl.

Mean Corpuscular Hemoglobin Concentration, pg

Absolute Neutrophil Count, 106

Cells/L

0

5.15

118

92.8

316

3.05

44

1.79

45

127.3

41.1

0.9

45

11.03

70

114.5

35.6

8.34

49

9.04

97

86.3

30

7.74